Lonza | LONN - Selling And Administration Expenses



Lonza reported 20.7M in Selling and Administration Expenses for its fiscal semester ending in December of 2022.


Selling And Administration Expenses Change Date
Akzo Nobel EUR 826M 29M Jun/2025
Alcon AG USD 870M 57M Jun/2025
Almirall EUR 91.3M 55.52M Mar/2025
AstraZeneca USD 5.01B 1.42B Jun/2025
BASF EUR 2.58B 67M Jun/2025
Bayer EUR 3.55B 162M Jun/2025
Beiersdorf EUR 322M 1.68B Jun/2025
Covestro EUR 449M 28M Jun/2025
Demant DKK 5.95B 319M Jun/2025
Fresenius EUR 740M 97M Jun/2025
Fresenius Medical Care EUR 792M 41M Jun/2025
Geberit CHF 226M 38.6M Mar/2025
Genmab DKK 144M 18M Jun/2025
Givaudan CHF 294.5M 229.5M Jun/2024
GlaxoSmithKline GBP 2.14B 80M Jun/2025
GN Store Nord DKK 1.42B 101M Jun/2025
Hikma Pharmaceutical USD 288M 8M Dec/2024
Johnson Matthey GBP 257M 4M Mar/2025
Merck EUR 1.48B 9M Jun/2025
Novartis USD 3.44B 384M Jun/2025
Philips EUR 1.24B 9M Jun/2025
Roche Holding CHF 3.61B 381M Dec/2024
Sanofi EUR 2.63B 408M Jun/2025
Sika AG CHF 547.85M 506.05M Jun/2024
Smith & Nephew USD 1.42B 77.8M Jun/2025
Solvay EUR 114M 9M Jun/2025
UCB EUR 1.29B 221M Dec/2024